(Q38209738)

31 August 2017

title

Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan (English)

1 reference

disseminated intravascular coagulation

31 August 2017

0 references

0 references

1 reference

1 reference

1 reference

T Iba

1

1 reference

31 August 2017

S Gando

series ordinal

2

1 reference

31 August 2017

J Thachil

series ordinal

3

1 reference

31 August 2017

publication date

19 June 2014

1 reference

Journal of Thrombosis and Haemostasis

31 August 2017

published in

1 reference

31 August 2017

volume

12

1 reference

31 August 2017

issue

7

1 reference

31 August 2017

page(s)

1010-1019

1 reference

Endotoxin removal devices for the treatment of sepsis and septic shock

31 August 2017

cites work

1 reference

Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry

21 January 2018

1 reference

The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study

21 January 2018

1 reference

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012

21 January 2018

1 reference

Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines.

21 January 2018

1 reference

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

21 January 2018

1 reference

Expert consensus for the treatment of disseminated intravascular coagulation in Japan

21 January 2018

1 reference

Hidden evidence to the West: multicentre, randomised, controlled trials in sepsis and systemic inflammatory response syndrome in Japanese journals

21 January 2018

1 reference

Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis

21 January 2018

1 reference

The interaction between pathogens and the host coagulation system

21 January 2018

1 reference

Combination of antithrombin and recombinant thrombomodulin attenuates leukocyte-endothelial interaction and suppresses the increase of intrinsic damage-associated molecular patterns in endotoxemic rats

21 January 2018

1 reference

21 January 2018

Sepsis and thrombosis

1 reference

Pathogen recognition by the innate immune system

21 January 2018

1 reference

Harmful molecular mechanisms in sepsis

21 January 2018

1 reference

Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

21 January 2018

1 reference

Molecular biology of inflammation and sepsis: a primer

21 January 2018

1 reference

Damage- and pathogen-associated molecular patterns and alarmins: keys to sepsis?

21 January 2018

1 reference

Neutrophil extracellular traps kill bacteria

21 January 2018

1 reference

Thrombosis as an intravascular effector of innate immunity

21 January 2018

1 reference

Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation

21 January 2018

1 reference

Novel cell death program leads to neutrophil extracellular traps

21 January 2018

1 reference

Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood

21 January 2018

1 reference

Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo.

21 January 2018

1 reference

Histones induce rapid and profound thrombocytopenia in mice

21 January 2018

1 reference

Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis

21 January 2018

1 reference

Extracellular histones are major mediators of death in sepsis

21 January 2018

1 reference

Binding of the von Willebrand factor A1 domain to histone.

21 January 2018

1 reference

Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones

21 January 2018

1 reference

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology

21 January 2018

1 reference

Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).

21 January 2018

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

21 January 2018

1 reference

Drotrecogin alfa (activated) in adults with septic shock.

21 January 2018

1 reference

Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression

21 January 2018

1 reference

Activated protein C and septic shock: a propensity-matched cohort study*.

21 January 2018

1 reference

Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway

21 January 2018

1 reference

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

High-dose antithrombin therapy for sepsis: mechanisms of action

21 January 2018

1 reference

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

21 January 2018

1 reference

A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis

21 January 2018

1 reference

A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis

21 January 2018

1 reference

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey

21 January 2018

1 reference

Therapeutic rationale for antithrombin III in sepsis

21 January 2018

1 reference

Quantification of antithrombin isoform proportions in plasma samples of healthy subjects, sepsis patients, and in antithrombin concentrates

21 January 2018

1 reference

Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.

21 January 2018

1 reference

Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism

21 January 2018

1 reference

Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis.

21 January 2018

1 reference

Bleeding and coagulopathies in critical care

21 January 2018

1 reference

A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria

21 January 2018

1 reference

Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)--a multicenter co-operative double-blind trial in comparison with heparin

21 January 2018

1 reference

International differences in the treatment of sepsis: are they justified?

21 January 2018

1 reference

Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JTH.12596

1 reference

31 August 2017

1 reference